Abstract
Photodynamic therapy (PDT) involves the parenteral administration of a photosensitising agent with some selectivity for malignant tissue. When activated by light, usually from a laser, local tissue destruction occurs. The amount of tissue destruction is dependent on the concentration of the photosensitising agent in the tissue and the light energy delivered. By careful manipulation of laser energy and photosensitiser dosage true selective destruction of malignant tissue can be produced in experimental colon cancers with total sparing of normal colon although under these conditions, the extent of necrosis in the tumour is only 2–3 mm from the light source. In addition, PDT has been shown not to reduce the mechanical strength of the colon even if full thickness necrosis is produced in normal areas. In contrast, thermal full thickness laser damage of the colon considerably weakens the colonic wall and may cause perforation. Light microscopy with specific collagen stains and electron microscopy have shown that the submucosal collagen layer is preserved following PDT, but is destroyed by thermal laser therapy. An initial clinical trial of PDT has been performed in ten patients with inoperable tumours because of advanced metastatic disease or severe medical problems. PDT has been shown to be safe and some small colorectal cancers can be totally eradicated.
Similar content being viewed by others
References
Raab O (1900) Über die Wirkung fluoreszierender Stoffe auf Infusorien. Z Biol 39:524
Jesionek A, von Tappiener H (1903) Zur Behandlung der Hautcarcinome mit fluoreszierenden Stoffen. Münch Med Wochschr 47:2042–2044
Meyer-Betz F (1913). Untersuchungen über die biologische (photodynamische) Wirkung des Hämatoporphyrins und anderer Derivate des Blut- und Gallenfarbstoffs. Dtsch Arch Klin Med 112:476–503
Polichard A (1924) Étude sur les aspects offerts par des tumeurs éxperimentales examinées a lumière de wood. Biologie (Comptes Rendus) 91:1423–1424
Auler H, Banzer G (1942) Untersuchungen über die Rolle der Porphyrine bei Geschwulstkranken und Tieren. Z Krebsforsch 53:65–68
Schwartz S, Absolon K, Vermund H (1955) Some relationships of porphyrins, X-rays, and tumors. Bull Minn Univ Sch Med 27:7–13
Hayata Y, Kato H, Konaka C, Ono J, Takizawa N (1982) Hematoporphyrin derivative and laser photoirradiation in the treatment of lung cancer. Chest 81:269–277
McCaughen JS, Hicks W, Laufman L, May E, Roach R (1984) Palliation of oesophageal malignancy with photoradiation therapy. Cancer 54:2905–2910
Barr H, Tralau CJ, MacRobert AJ, Krasner N, Boulos PB, Clark CG, Brown SG (1987) Photodynamic therapy with phthalocyanine sensitisation in the normal rat colon. Br J Cancer 55:389–395
Barr H, Tralau CJ, Boulos PB, MacRobert AJ, Tilly R, Brown SG (1987) The contrasting mechanisms of colonic damage between photodynamic therapy and thermal injury. Photochem Photobiol 46:795–800
Gregorie HB, Horger EO, Ward JL, Green JF, Richards T, Robertson HC, Stevenson TB (1968) Hematoporphyrinderivative fluorescence in malignant neoplasms. Ann Surg 167:820–828
Klingenstein RJ, May RJ (1982) Uptake of hematoporphyrin by colonic adenocarcinoma in the rat. Gastroenterology 82:1102
Agrev MV, Wharen RE Jr, Anderson RE, Laws ER, Ilstrup DM, Cortese DA, Shorter RG, Lieber MM (1983) Hematoporphyrin derivative: quantitative uptake in dimethylhydrazine-induced murine colorectal carcinoma. J Surg Oncol 24:173–176
Tralau CJ, Barr H, Sandeman DR, Barton T, Lewin MR, Brown SG (1987) Aluminum sulfonated phthalocyanine distribution in tumours of the colon, brain and pancreas. Photochem Photobiol 46:777–781
Barr H, Tralau CJ, MacRobert AJ, Morrison I, Phillips D, Bown SG (1988) Fluorescence photometric techniques for the determination of microscopic tissue distribution of phthalocyanine photosensitizers for photodynamic therapy. Lasers Med Sci 3:81–86
Bugelski P, Porter CW, Dougherty TJ (1981) Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res 41:4606–4612
Bown SG, Tralau CJ, Coleridge-Smith PD, Akdemir D, Weiman TJ (1986) Photodynamic therapy with porphyrin and phthalocyanine sensitisation in normal rat liver. Br J Cancer 54:43–52
Svaasand LO (1984) Thermal and optical dosimetry for photoradiation therapy of malignant tumors. In: Porphyrins in tumor phototherapy. Andreoni A, Cubeddu R (eds) Plenum Press, New York, pp 261–279
Wilson BC, Patterson MS, Burns DM (1986) Effect of photosensitizer concentration in tissue on the penetration depth of photoactivating light. Lasers Med Sci 1:235–244
Berenbaum MC, Bonnett R, Scourides PA (1982) In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer 45:571–581
Cowled PA, Forbes IJ (1985) Photocytotoxicity in vivo of haematoporphyrin components. Cancer Lett 28:111–118
Barr H, Tralau CJ, Lewin M, Clark CG, Bown SG, Boulos PB (1988) Selective destruction of experimental colon cancer using photodynamic therapy. Br J Surg 75:611–612
Potter WR, Mang TS, Dougherty TJ (1987) The theory of photodynamic dosimetry: consequences of photodestruction of sensitizer. Photochem Photobiol 46:97–101
Barr H, Bown SG, Krasner N (1987) Photodynamic therapy for advanced colorectal cancer. Gut 28:A1368
Cortese DA, Kinsey JH (1982) Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy. Mayo Clin Proc 57:543–547
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barr, H., Bown, S.G., Krasner, N. et al. Photodynamic therapy for colorectal disease. Int J Colorect Dis 4, 15–19 (1989). https://doi.org/10.1007/BF01648544
Issue Date:
DOI: https://doi.org/10.1007/BF01648544